Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012-2013
| dc.contributor.author | Álvarez, Josep | |
| dc.contributor.author | Godoy i García, Pere | |
| dc.contributor.author | Plans Rubio, Pedro | |
| dc.contributor.author | Camps, Neus | |
| dc.contributor.author | Carol, Mónica | |
| dc.contributor.author | Carmona i Parcerisa, Glòria | |
| dc.contributor.author | Solano, Rubén | |
| dc.contributor.author | Rius, Cristina | |
| dc.contributor.author | Minguell, Sofía | |
| dc.contributor.author | Barrabeig i Fabregat, Irene | |
| dc.contributor.author | Sala Farré, Maria Rosa | |
| dc.contributor.author | Rodríguez, Raquel | |
| dc.contributor.author | Garcia Cenoz, Manuel | |
| dc.contributor.author | Muñoz Almagro, Carmen | |
| dc.contributor.author | Domínguez García, Àngela | |
| dc.contributor.author | Transmission of Pertussis in Households Working Group | |
| dc.date.accessioned | 2023-03-09T16:13:47Z | |
| dc.date.available | 2023-03-09T16:13:47Z | |
| dc.date.issued | 2020-11-01 | |
| dc.date.updated | 2023-03-09T16:13:47Z | |
| dc.description.abstract | We retrospectively assessed the effectiveness of azithromycin in preventing transmission of pertussis to a patient's household contacts. We also considered the duration between symptom onset in the primary patient and azithromycin administration. We categorized contacts into 4 groups: those treated within <7 days, 8-14 days, 15-21 days, and >21 days after illness onset in the primary patient. We studied 476 primary index patients and their 1,975 household contacts, of whom 4.5% were later identified as having pertussis. When contacts started chemoprophylaxis within <21 days after the primary patient's symptom onset, the treatment was 43.9% effective. Chemoprophylaxis started >14 days after primary patient's symptom onset was less effective. We recommend that contacts of persons with pertussis begin chemoprophylaxis within <14 days after primary patient's symptom onset. | |
| dc.format.extent | 7 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 705180 | |
| dc.identifier.issn | 1080-6040 | |
| dc.identifier.uri | https://hdl.handle.net/2445/194952 | |
| dc.language.iso | eng | |
| dc.publisher | Centers for Disease Control and Prevention | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3201/eid2611.181418 | |
| dc.relation.ispartof | Emerging Infectious Diseases, 2020, vol. 26, num. 11, p. 2678-2684 | |
| dc.relation.uri | https://doi.org/10.3201/eid2611.181418 | |
| dc.rights | Domini públic / Public domain | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/publicdomain/zero/1.0/ | * |
| dc.source | Articles publicats en revistes (Medicina) | |
| dc.subject.classification | Tos ferina | |
| dc.subject.classification | Terapèutica | |
| dc.subject.other | Whooping cough | |
| dc.subject.other | Therapeutics | |
| dc.title | Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012-2013 | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1